Cancer prevalence higher with long duration of diabetes

January 24, 2013
Cancer prevalence higher with long duration of diabetes
Patients diagnosed with type 2 diabetes have a greater prevalence of cancer with longer diabetes duration and with insulin use, according to a study published online Jan. 8 in Diabetes Care.

(HealthDay)—Patients diagnosed with type 2 diabetes have a greater prevalence of cancer with longer diabetes duration and with insulin use, according to a study published online Jan. 8 in Diabetes Care.

Chaoyang Li, M.D., Ph.D., and colleagues from the U.S. Centers for Disease Control and Prevention in Atlanta, estimated the prevalence of diagnosed cancer using data for 25,964 adults with diagnosed diabetes from the 2009 Surveillance System.

The researchers found that, after adjustment for a number of variables, the prevalence of cancer was significantly higher with greater duration of diabetes. For adults with , the prevalence of cancer was significantly higher among those diagnosed with diabetes at least 15 years earlier (adjusted prevalence ratio, 1.6 for men and 1.8 for women). The prevalence of cancer of all sites was also higher among patients with type 2 diabetes who used insulin (1.3 for both men and women).

"While our cross-sectional results provide useful information for an association between duration of diagnosed diabetes or current insulin use and cancer prevalence, further clinical research with a longitudinal design is warranted to confirm a possible causal link between diabetes and cancer," Li and colleagues conclude.

Explore further: Diabetes linked to lung cancer in postmenopausal women

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Diabetes linked to lung cancer in postmenopausal women

May 30, 2012

(HealthDay) -- Postmenopausal women with diabetes are at a significantly higher risk of developing lung cancer, particularly if they require insulin therapy, according to research published online May 22 in Diabetes Care.

Lung cancer risk unaffected by metformin use in diabetes

August 30, 2012

(HealthDay)—Patients with type 2 diabetes who take metformin do not have a reduced risk of lung cancer, in contrast to previous observational studies, according to a study published online Aug. 24 in Diabetes Care.

Increasing shift from islet antibody positivity to diabetes

March 2, 2012

(HealthDay) -- There is an increase in both the prevalence and levels of islet antigen-2 and zinc transporter 8, as well as in autoantibodies, in newly diagnosed type 1 diabetes patients during a period of rising disease ...

Recommended for you

New theory on how insulin resistance, metabolic disease begin

September 26, 2016

Does eating too much sugar cause type 2 diabetes? The answer may not be simple, but a study published Sept. 26 in the Journal of Clinical Investigation adds to growing research linking excessive sugar consumption—specifically ...

Unique molecular atlas of pancreas produced

September 23, 2016

Researchers at Karolinska Institutet have managed to produce the first molecular map of the genes that are active in the various cells of the human pancreas. They have also revealed differences in genetic activity between ...

Can long naps cause diabetes?

September 14, 2016

A study presented at a scientific congress Thursday reported a link between long naps and a higher risk of diabetes, though it couldn't say if daytime sleeping was a symptom or a cause.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.